CS logo
small CS logo
Indiana Blood and Marrow Transplantation

Indianapolis, Indiana, United States
Medical center in Indianapolis, Indiana
8111 S Emerson Ave, Indianapolis, IN 46237

About Indiana Blood and Marrow Transplantation


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
7
Incyte Corporation
6
Cogent Biosciences, Inc.
4
Genzyme, a Sanofi Company
4
Novartis Pharmaceuticals
4
Medical College of Wisconsin
3
Ansun Biopharma, Inc.
2
Cellerant Therapeutics
2
Center for International Blood and Marrow Transplant Research
2
Eli Lilly and Company
2
Leonard-Meron Biosciences, Inc.
2
Total Rows: 31

Clinical Trials at Indiana Blood and Marrow Transplantation


During the past decade, Indiana Blood and Marrow Transplantation conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 15 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1133558811006600440022112244Started TrialsCompleted Trails20152016201720182019202020210510
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation
2000-03-01
2003-05-01
Completed
Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
2000-09-01
2003-11-01
Completed
S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
2003-04-01
2006-06-01
Terminated
5
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)
2004-01-01
2014-04-01
Completed
551
Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)
2003-12-01
2013-03-01
Completed
710
Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)
2004-08-01
2009-03-01
Terminated
30
Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients
2005-01-01
2007-12-01
Completed
298
Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients
2005-01-01
2008-01-01
Completed
302

Rows per page:

1–59 of 59

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Indiana Blood and Marrow Transplantation" #1 sponsor was "Pfizer" with 7 trials, followed by "Incyte Corporation" with 6 trials sponsored, "Cogent Biosciences, Inc." with 4 trials sponsored, "Genzyme, a Sanofi Company" with 4 trials sponsored and "Novartis Pharmaceuticals" with 4 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 31 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana Blood and Marrow Transplantation" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 5 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "National Marrow Donor Program" with 4 trials as a collaborator and "Department of Health and Human Services" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 19 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 7Pfizer: 7Incyte Corporation: 6Incyte Corporation: 6Cogent Biosciences, Inc.: 4Cogent Biosciences, Inc.: 4Genzyme, a Sanofi Company: 4Genzyme, a Sanofi Company: 4Novartis Pharmaceuticals: 4Novartis Pharmaceuticals: 4Medical College of Wisconsin: 3Medical College of Wisconsin: 3Ansun Biopharma, Inc.: 2Ansun Biopharma, Inc.: 2Cellerant Therapeutics: 2Cellerant Therapeutics: 2Center for InternationalBlood and MarrowTransplant Research: 2Center for InternationalBlood and MarrowTransplant Research: 2Eli Lilly and Company: 2Eli Lilly and Company: 2

Created with Highcharts 11.1.0Top CollaboratorsNational Cancer Institute (NCI): 6National Cancer Institute (NCI): 6Blood and MarrowTransplant Clinical TrialsNetwork: 5Blood and MarrowTransplant Clinical TrialsNetwork: 5National Heart, Lung,and Blood Institute(NHLBI): 5National Heart, Lung,and Blood Institute(NHLBI): 5National Marrow DonorProgram: 4National Marrow DonorProgram: 4Department of Healthand Human Services: 2Department of Healthand Human Services: 2National Institutes ofHealth (NIH): 2National Institutes ofHealth (NIH): 2AbbVie: 1AbbVie: 1Basilea PharmaceuticaInternational Ltd: 1Basilea PharmaceuticaInternational Ltd: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1DevelopmentalTherapeuticsConsortium: 1DevelopmentalTherapeuticsConsortium: 1

Clinical Trials Conditions at Indiana Blood and Marrow Transplantation


According to Clinical.Site data, the most researched conditions in "Indiana Blood and Marrow Transplantation" are "Multiple Myeloma" (8 trials), "Acute Myeloid Leukemia" (6 trials), "Chronic Myeloid Leukemia" (5 trials), "Lymphoma" (4 trials) and "Lymphoma, Non-Hodgkin" (4 trials). Many other conditions were trialed in "Indiana Blood and Marrow Transplantation" in a lesser frequency.

Clinical Trials Intervention Types at Indiana Blood and Marrow Transplantation


Most popular intervention types in "Indiana Blood and Marrow Transplantation" are "Drug" (46 trials), "Biological" (13 trials), "Procedure" (4 trials), "Radiation" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Bosutinib" (4 trials), "Imatinib" (3 trials), "Parsaclisib" (3 trials) and "ACTR087" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Indiana Blood and Marrow Transplantation


The vast majority of trials in "Indiana Blood and Marrow Transplantation" are 59 trials for "All" genders.

Clinical Trials Status at Indiana Blood and Marrow Transplantation


Currently, there are NaN active trials in "Indiana Blood and Marrow Transplantation". undefined are not yet recruiting, 4 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Indiana Blood and Marrow Transplantation, undefined suspended trials, and 11 terminated clinical trials to date.
Out of the total trials that were conducted in Indiana Blood and Marrow Transplantation, 10 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 24Phase 2: 24Phase 3: 20Phase 3: 20Phase 1: 10Phase 1: 10Early Phase 1: 1Early Phase 1: 1Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 29Completed: 29Active, not recruiting: 11Active, not recruiting: 11Terminated: 11Terminated: 11Recruiting: 4Recruiting: 4No longer available: 2No longer available: 2Approved for marketing: 1Approved for marketing: 1Available: 1Available: 1